CEO of Bond Digital Health, Ian Smith, explains how the world has woken up to lateral flow testing and following the pandemic the market is realising that “a lot more can be done in regards to diagnostics”.
Following his appointment last year, Ian Smith has now settled into the role of CEO. He is an experienced company director who has held CEO and CFO roles in businesses in various sectors, including health technology, medical technology, biotech and finance. He was most recently CEO of Time Finance plc, an AIM-listed company offering business finance solutions to SMEs.
Throughout his career Ian, a qualified chartered accountant, has helped businesses commercialise R&D, manage rapid growth, raise development capital, merge, and float on the stock exchange.
Listen to an audio interview with Ian Smith here:
